Clinical Trials Logo

Lateral Canthal Lines clinical trials

View clinical trials related to Lateral Canthal Lines.

Filter by:

NCT ID: NCT03655691 Completed - Clinical trials for Lateral Canthal Lines

ET-01 in Subjects With Lateral Canthal Lines, LCL-207

Start date: August 16, 2018
Phase: Phase 2
Study type: Interventional

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

NCT ID: NCT03326856 Completed - Clinical trials for Lateral Canthal Lines

ET-01 in Subjects With Lateral Canthal Lines

Start date: October 25, 2017
Phase: Phase 2
Study type: Interventional

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

NCT ID: NCT02248844 Completed - Clinical trials for Lateral Canthal Lines

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Start date: September 26, 2014
Phase:
Study type: Observational

This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.

NCT ID: NCT02195687 Completed - Clinical trials for Lateral Canthal Lines

BOTOX® in the Treatment of Crow's Feet Lines in China

Start date: September 2014
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) compared with placebo in patients with moderate to severe crow's feet lines (lateral canthal lines).

NCT ID: NCT01951742 Completed - Clinical trials for Lateral Canthal Lines

Dose Finding Study In Subjects With Crow's Feet

Start date: September 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to establish the therapeutic range of ANT-1401 in the treatment of Crow's Feet.

NCT ID: NCT01809964 Completed - Clinical trials for Lateral Canthal Lines

Clinical Trial to Evaluate ANT-1401 in Crow's Feet

Start date: March 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to confirm the effect of ANT-1401 in the treatment of Lateral Canthal Lines.

NCT ID: NCT01358695 Completed - Clinical trials for Lateral Canthal Lines

Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

Start date: May 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.

NCT ID: NCT01124565 Completed - Facial Wrinkles Clinical Trials

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Start date: May 2010
Phase: Phase 2
Study type: Interventional

This study's objective is to evaluate if RT001 is safe and well-tolerated following two (2) sequential applications.

NCT ID: NCT01124552 Completed - Facial Wrinkles Clinical Trials

A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Start date: April 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out if an investigational drug, called RT001 Topical Gel, is safe and useful in minimizing the wrinkles between the eye and hairline called lateral canthal lines, also known as crow's feet wrinkles.

NCT ID: NCT01064518 Completed - Facial Wrinkles Clinical Trials

Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Start date: January 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out if an investigational drug, called RT001 Botulinum Toxin Type A Topical Gel, is safe and useful in minimizing the wrinkles between the eye and hairline called crow's feet, also known as lateral canthal lines.